Oral cholesterol-lowering therapies: The basis of prevention10' education - Oct. 2, 2023 - Lale Tokgözoğlu, MD - Ankara, Turkey
Video navigation menu
- Effects of statins 01:13
- Ezetimibe 03:45
- Bile acid sequestrants 05:20
- Bempedoic acid 05:52
- Oral PCSK9 inhibitor 07:38
- Average LDL-c reduction with different combinations of oral therapies 08:09
- Conclusion 08:33
This lecture by Lale Tokgözoğlu was part of the EBAC-accredited symposium "The LDL-c challenge in high cardiovascular risk: Integrating innovative therapies in clinical management" held during the ESC congress 2023.
Lale Tokgözoğlu, MD is Professor of Cardiology at Hacettepe University in Ankara, Turkey.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Amgen, NewAmsterdam Pharma, Sanofi and Viatris.